tirzepatide updates FDA approval for Zepbound (tirzepatide) injection, the first and only obesity treatment of its kind that activates both GIP and GLP-1 hormone receptors - Eli Lilly FDA Drug Recalls and Warnings:

Defense Against Liver Diseases Research suggests that glutathione may act as a safeguard against various liver diseases, including non-alcoholic fatty liver disease (NAFLD), alcoholic liver disease, and viral hepatitis

10.1152/ajpgi.00194.2019 24 BaldiniF.HertelJ.SandtE.ThinnesC

Such an imbalance can be the result of several factors: stress-induced over-production of free radicals, a lack of exogenous antioxidants in the diet, a failure of internal defence systems, or increased exposure to reactive species (through smoking, alcohol, pollution ) If it persists, oxidative stress can dramatically affect the bodys principal constituents cells, fatty acids, proteins (such as DNA), sugars contributing to the development of chronic health problems (1-2)

"We found that fewer than 1 in 4 patients remained on a GLP-1 medication after a year," says Dr